Free Trial

Vaccinex (VCNX) Insider Trading & Ownership

Vaccinex logo
$3.56 +0.30 (+9.20%)
(As of 12:16 PM ET)

Vaccinex (NASDAQ:VCNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
51.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.25 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$2,257.92
Get VCNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vaccinex stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VCNX Insider Buying and Selling by Quarter

Vaccinex Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2024Albert FriedbergDirectorBuy100$4.51$451.00  
8/5/2024Albert FriedbergDirectorBuy3,653$4.60$16,803.80  
7/31/2024Albert FriedbergDirectorBuy200,000$6.15$1,230,000.00  
5/29/2024Albert FriedbergDirectorBuy957$4.95$4,737.15  
4/19/2024Albert FriedbergDirectorBuy282$4.73$1,333.86  
12/26/2023Strydonck Gerald E. VanDirectorSell224$10.08$2,257.92  
(Data available from 1/1/2013 forward)

VCNX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Vaccinex includes Albert Friedberg, Jacob B Frieberg, Maurice Zauderer, Strydonck Gerald E Van. Learn more on insiders at VCNX.

51.50% of Vaccinex stock is owned by insiders. Learn more on VCNX's insider holdings.

The following insiders have purchased VCNX shares in the last 24 months: Albert Friedberg ($4,253,315.81), and Maurice Zauderer ($4,648.14).

Insiders have purchased a total of 419,634 VCNX shares in the last 24 months for a total of $4,257,963.95 bought.

The following insider sold VCNX shares in the last 24 months: Strydonck Gerald E. Van ($2,257.92).

Insiders have sold a total of 224 Vaccinex shares in the last 24 months for a total of $2,257.92 sold.

Vaccinex Key Executives

  • Dr. Maurice Zauderer Ph.D. (Age 77)
    Co-Founder, CEO, President & Director
    Compensation: $411.7k
  • Dr. Elizabeth E. Evans Ph.D. (Age 51)
    COO and Senior VP of Discovery & Translational Medicine
    Compensation: $291.57k
  • Dr. Ernest S. Smith Ph.D. (Age 52)
    Senior VP of Research & Chief Scientific Officer
    Compensation: $297.25k
  • Ms. Jill Sanchez CPA (Age 52)
    Chief Financial Officer
  • Dr. John E. Leonard Ph.D. (Age 77)
    Senior Vice President of Development


This page (NASDAQ:VCNX) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners